Skip to main content

LAZARD ASSET MANAGEMENT LLC

Position in ESPR — Esperion Therapeutics, Inc.

CIK 1207017 NEW YORK, NY

Position in ESPR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
580,705
+1621.1% QoQ
Ownership
0.226%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ESPR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

LAZARD ASSET MANAGEMENT LLC holds $122,207,057 across 17 Drug Manufacturers - Specialty & Generic names.

# Ticker Company Shares Value (USD) Open

All Filings in ESPR

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 580,705
2025-12-31 33,741
2025-03-31 43,815
2024-12-31 12,351
2024-09-30 12,351
2024-06-30 11,694
2022-12-31 145,953
2022-09-30 83,568
2022-06-30 32,392
2022-03-31 56,427
2021-12-31 36,291
2021-09-30 169,400
2021-06-30 27,000